erts a spectrum of energy-preserving actions on the heart including negative chronotropic effects. The pathways leading to adenosine formation have remained controversial. In particular, although cytosolic 5Ј-nucleotidases can catalyze adenosine formation in cardiomyocytes, their contribution to the actions of adenosine has not been documented previously. We recently cloned two closely related AMP-preferring cytosolic 5Ј-nucleotidases (cN-IA and -IB); the A form predominates in the heart. In this study, we overexpressed pigeon cN-IA in neonatal rat cardiomyocytes using an adenovirus. cN-IA overexpression increased adenosine formation and release into the medium caused by simulated hypoxia and by isoproterenol in the absence and presence of inhibitors of adenosine metabolism. Adenosine release was not affected by an ecto-5Ј-nucleotidase inhibitor, ␣,␤-methylene-ADP, but was affected by a nucleoside transporter, dipyridamole. The positive chronotropic effect of isoproterenol (130 Ϯ3 vs. 100 Ϯ4 beats/min) was inhibited (107 Ϯ3 vs. 94 Ϯ3 beats/min) in cells overexpressing cN-IA, and this was reversed by the addition of the adenosine receptor antagonist 8-(p-sulfophenyl)theophilline (120 Ϯ 3 vs. 90 Ϯ 4 beats/min). Our results demonstrate that overexpressed cN-IA can be sufficiently active in cardiomyocytes to generate physiologically effective concentrations of adenosine at its receptors. chronotropic effect; catecholamines; ATP metabolism ADENOSINE EXERTS A SPECTRUM of actions on the heart that include increasing coronary blood flow (2, 31), antagonizing the effects of catecholamines both pre-and postsynaptically (18, 32), and prolonging atrioventricular conduction time (16). These actions are brought about by a family of cell surface adenosine receptors that have been extensively characterized (34). All the actions of adenosine on the heart tend to increase energy supply or reduce energy demand. Moreover, there appears to be a direct link between energy utilization and the rate of adenosine formation, which suggests that adenosine functions physiologically as a cardioprotective metabolite (24). The role of adenosine in ischemic preconditioning (22) may also be an extension of this concept.
chronotropic effect; catecholamines; ATP metabolism ADENOSINE EXERTS A SPECTRUM of actions on the heart that include increasing coronary blood flow (2, 31) , antagonizing the effects of catecholamines both pre-and postsynaptically (18, 32) , and prolonging atrioventricular conduction time (16) . These actions are brought about by a family of cell surface adenosine receptors that have been extensively characterized (34) . All the actions of adenosine on the heart tend to increase energy supply or reduce energy demand. Moreover, there appears to be a direct link between energy utilization and the rate of adenosine formation, which suggests that adenosine functions physiologically as a cardioprotective metabolite (24) . The role of adenosine in ischemic preconditioning (22) may also be an extension of this concept.
Ecto-5Ј-nucleotidase (e-N) can catalyze the terminal dephosphorylation of AMP to adenosine. Biochemical experiments with inhibitors and cloning have demonstrated conclusively that this enzyme is only capable of metabolizing extracellular nucleotides, in a cascade with other ectoenzymes (39) . Consistent with this, adenosine derived from AMP perfused through the heart requires e-N (25) . However, a link between intracellular energy utilization, nucleotide release, and e-N activity is at best controversial. In neonatal myocytes, adenosine formation induced by chemical hypoxia occurs exclusively intracellularly (21) , although the extracellular pathway may also contribute in adult myocytes (4) . The situation in the whole heart is more complicated due to the contribution made by the vasculature and nerve terminals. Experimental evidence has been presented in favor (13, 15) and against (3, 33) the involvement of the ecto pathway under normoxic and hypoxic conditions. Deussen and colleagues (7) used trapping of adenosine through S-adenosylhomocysteine hydrolase and mathematical modelling to estimate the contribution of cytosolic and extracellular pathways to adenosine production in normoxic guinea pig hearts. They concluded that 8-11% of adenosine production is derived from extracellular metabolism. However, increased adenosine formation in hearts stimulated by catecholamines (8, 9) apparently does not involve e-N (3, 19) .
Alternatively, adenosine could be formed from cytosolic AMP, which rises during ATP breakdown owing to the myokinase equilibrium, by the action of a cytosolic 5Ј-nucleotidase (cN). Adenosine might then be released from cells via equilibrative nucleoside transporters (17) . An IMP-preferring enzyme, cN-II, was cloned and overexpressed and shown to selectively catalyze conversion of IMP to inosine rather than AMP to adenosine (28) . An AMP-preferring enzyme was originally cloned from the pigeon (30) and then from the human and mouse (14, 29) . When overexpressed, this enzyme selectively catalyzed conversion of AMP to adenosine. Furthermore, selective inhibitors of cN-I inhibit adenosine formation from rat adult myocytes under chemical hypoxia (11) . Interestingly, two cN-I genes were identified; cN-IA, the form originally purified and cloned from the pigeon, is abundantly ex-pressed in the pigeon and human heart (14, 30) . cN-IB is abundant in the testis, where it was also cloned as human autoimmune infertility-related antigen (GenBank Accession No. AF356185). Doubts remain regarding the role of cN-I in the myocardial actions of adenosine, in particular because its Michaelis-Menten constant (K m ) for AMP measured in the test tube is ϳ5 mM, much higher than predicted cytosolic AMP concentrations. In addition, most previous studies of cN-I activity have used inhibitors of adenosine kinase and adenosine deaminase to prevent further metabolism. While these studies provide absolute rates of adenosine formation, they leave unanswered the question of whether sufficient adenosine can escape metabolism so as to carry out physiological effects at extracellular receptors. In the present study, we overexpressed pigeon cN-IA in rat cardiomyocytes using adenovirus-mediated gene transfer. We then studied adenosine formation under simulated hypoxia with and, importantly, without inhibitors of adenosine metabolism. Finally, we investigated the influence of cN-IA overexpression on a physiological response, namely, the beating rate in cardiomyocytes stimulated with isoproterenol.
MATERIALS AND METHODS

Materials.
Tissue culture products were from Invitrogen. Molecular biology reagents, nucleotides and nucleosides, and the cell cytotoxicity test [lactate dehydrogenase (LDH) measurement] were from Roche Biochemicals. Reagents for Western blotting were from Amersham, and those for immunocytochemistry were from from DAKO. General laboratory reagents and chemicals were obtained from Sigma.
Construction of a recombinant adenoviral vector. The coding sequence of pigeon cN-IA was excised with BamHI and KpnI and subcloned into the shuttle vector pDC 515 downstream from the mouse cytomegalovirus promoter (Microbix Biosystems Canada). Replication-deficient adenovirus was generated by site-specific FLP-mediated recombination of the cotransfected shuttle and genomic plasmids in 293 cells. Viral stocks were plaque purified, amplified, CsCl banded, and titrated according to the manufacturer's instructions.
Culture and infection of rat neonatal cardiomyocytes. Myocytes were isolated from 2-to 3-day-old rats by four cycles of digestion in 0.1% trypsin containing 0.02% EDTA in PBS. All the animal procedures used in these studies were performed in accordance with the guidelines and regulations of the University of Bristol and the United Kingdom Home Office. Digestion was stopped by the addition of fetal calf serum (FCS) to 20%. The dispersed cells were resuspended in MEM supplemented with 10% FCS, 100 g/ml streptomycin, and 100 U/ml penicillin and preplated for 1 h to allow fibroblasts to adhere. The suspended myocytes were seeded on plates previously coated with 1% gelatin in PBS for 1 h; 10 6 myocytes were seeded in 35-mm dishes for beating rate measurements or 5 ϫ 10 5 myocytes on 12-well plates for metabolite assays. After 40 h in culture, Ͼ80% of the cells were beating spontaneously. The culture medium was then changed to 4:1 DMEM-M199, containing antibiotics and 1% FCS, and adenoviral infection was performed. A previously described adenovirus expressing ␤-galactosidase (37) was used to control for the nonspecific effects of viral infection.
Metabolic studies. Cells in 12-well dishes were washed in saline, transferred to Krebs-Ringer-HEPES (KRH) buffer [containing (in mM) 120 NaCl, 4.8 KCl, 1.2 KH 2PO4, 1.2 MgSO4, 1.3 CaCl2, and 25 HEPES; pH 7.3], and preincubated for 10 min at 37°C. Metabolic inhibition was triggered with 10 mM 2-deoxyglucose (DOG), 10 mM DOG plus 1 mM sodium dithionite (S 2O4), or 10 mM DOG plus 0.5 mM sodium cyanide. Control cells were incubated in control buffer (KRH buffer containing 5.5 mM glucose and 1 mM sodium pyruvate). Adenosine formation caused by ␤-adrenergic stimulation with 20 M isoproterenol was measured in control buffer. To inhibit adenosine metabolism, 10 M erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA), an inhibitor of adenosine deaminase (EC 3.5.4.4) (23), and 50 M 5Ј-amino-5Ј-deoxyadenosine (5Ј-NH 2), to inhibit adenosine kinase (EC 2.7.1.20) (23) , were included in some experiments. The nucleoside transport inhibitor dipyridamole was added at a final concentration of 10 M from a 10 mM solution in DMSO. Cell incubations were terminated by the addition of 0.75 volumes of 1.6 M HClO 4, and total purines and protein concentrations were determined by HPLC as previously described (30) . Separate experiments were conducted to measure adenosine in the medium by HPLC. To stop incubations, 300 l of the supernatant buffer were removed and frozen immediately. After the rest of the buffer was carefully removed, 400 l of 1.2 M HClO 4 were added to assay purines and protein in the cell pellet as described above. Cell viability was assessed by measurement of LDH in cell supernatants at the end of the incubations and expressed as a percentage of the total LDH present in parallel wells extracted in KRH buffer containing 0.1% Triton X-100.
Activities of purine metabolizing enzymes. Cell extracts were prepared in buffer containing 20 mM Na dimethylglutarate, 20 mM Na ␤-glycerophosphate, 100 mM KCl, 0.1 mM DTT, 0.1% Triton X-100, and a Sigma protease inhibitory cocktail (P8340); pH 6.9. Assays for cN-I were performed in extraction buffer with near-saturating substrate concentrations (10 mM AMP) in the presence of the activator ADP (1 mM), the selective e-N inhibitor, ␣,␤-methylene-ADP (50 M), the inhibitor of adenosine deaminase pentostatin (2 M), and 5Ј-NH 2 (10 M) (30) . e-N was assayed in buffer containing 50 mM Tris ⅐ HCl, 10 mM Na ␤-glycerophosphate, 5 mM MgCl 2, and 0.1% Triton X-100 (pH 8.0) containing 0.2 mM AMP as the substrate in the presence of the inhibitor of adenosine deaminase pentostatin (2 M) and the adenosine kinase inhibitor 5Ј-NH 2 (10 M). AMP deaminase was assayed in buffer containing (in mM) 20 Na dimethylglutarate, 1 EDTA, 0.1 DTT, and 150 KCl (pH 7.0) containing 15 mM AMP as the substrate and 1.5 mM ATP as the activator. Adenosine deaminase was measured in 50 mM potassium phosphate buffer (pH 7.4) containing 150 M adenosine. Aliquots of extracts containing 10-20 g protein were incubated for between 0 and 10 min at 37°C; the reactions were stopped by the addition of HClO 4, followed by analysis of the products by HPLC as already described (30) . Adenosine kinase was measured at 37°C in aliquots containing 1.5-3 g protein using [ 14 C]adenosine as the substrate (5). Effects of cN-IA overexpression on beating rates. Cells in 35-mm dishes were transferred to HEPES-buffered RPMI 1640 (0.8 ml). Beating rates were determined by counting the beats of four groups of cells for 1 min using a heated microscope stage maintained at 37°C. Determinations were made after equilibration for 10 min under all conditions used.
Western blots and immunocytochemistry. The generation of the rabbit polyclonal antibody against peptides derived from the sequence of pigeon cN-IA and the methods used for Western blotting have been described previously (30) .
Statistical analysis. Results are expressed as means Ϯ SE. Statistical significance was assessed with one-way ANOVA, followed by paired Student's t-test if appropriate or unpaired Student's t-test with Bonferroni correction for repeated measures. A value of P Ͻ 0.05 was considered significant.
RESULTS
Adenovirus-mediated overexpression of cN-IA in rat cardiomyocytes.
Infection of neonatal rat cardiomyocytes with a multiplicity of infection of 10 plaqueforming units/cell of an adenovirus that drives ␤-galactosidase expression transduced Ͼ90% of cells (Fig. 1A) . Infection with a similar virus engineered to express pigeon cN-IA led to overexpression of a protein of the correct size by Western blotting using a previously described antibody against a peptide epitope in pigeon cN-IA (Fig. 1B) . This was accompanied by an 18-fold increase in 5Ј-nucleotidase activity from 45 Ϯ 6 to 824 Ϯ 36 nmol ⅐ min Ϫ1 ⅐ mg protein Ϫ1 (n ϭ 7). By immunocytochemistry, using the same antibody as for Western blotting, Ͼ90% of cardiomyocytes in cN-IA-adenovirus-infected cultures stained for cN-IA (Fig. 1D) . The activity of other purine-metabolizing enzymes was similar in ␤-galactosidase-and cN-IA-transduced cells, as (23) . As shown in Table 1 , DOG, a glycolytic inhibitor, alone decreased ATP concentrations by ϳ40%. This was increased to ϳ55% by adding S 2 O 4 , which consumes molecular oxygen, and to ϳ70% by adding cyanide, an inhibitor of cytochrome oxidase (Table 1) . Transduction with ␤-galactosidase had no effect on baseline ATP concentration or ATP catabolism compared with untransduced cells (results not shown). The baseline ATP concentration was de- 
Values are mean Ϯ SE of 3 separate experiments unless otherwise stated. ATP concentrations measured by HPLC are expressed as a percentage of the corresponding values obtained from ␤-galactosidase or AMP-preferring cytosolic 5Ј-nucleotidase (cN-I) transduced cells incubated in Krebs-Ringer-HEPES (KRH) buffer (47 Ϯ 2 vs. 43 Ϯ 3 nmol ATP/mg protein, n ϭ 7, P Ͻ 0.05) or KRH ϩ erythro-9-(2-hydroxy-3-nanyl)adenine (EHNA) ϩ 5Ј-amino-5Ј-deoxyadenosine (5Ј-NH2) (48 Ϯ 3 vs. 44 Ϯ 3 nmol ATP/mg protein, n ϭ 3, P ϭ not significant. Lactate dehydrogenase (LDH) released into the medium is expressed as a percentage of the value in homogenates. * P Ͻ 0.05 vs. ␤-galactosidase transduction; † P Ͻ 0.003 when all experiments with dithionite are compared with those with 2-deoxyglucose (DOG) alone; ‡ P Ͻ 0.01 for cyanide versus DOG alone and P Ͻ 0.0001 when all experiments with cyanide are compared with those with DOG alone. creased significantly by 8% in cN-IA-transduced cardiomyocytes (43 Ϯ 3 nmol/mg protein, n ϭ 7) compared with ␤-galactosidase-transduced cells (47 Ϯ 2 nmol/mg protein, n ϭ 7, P Ͻ 0.02). Despite this, there was no difference in the percentage of ATP broken down between ␤-galactosidase-and cN-IA-transduced cells under any condition of chemical hypoxia (Table 1) . Including inhibitors of adenosine metabolism did not affect either the baseline ATP concentration in ␤-galactosidase-or cN-IA-transduced cells [48 Ϯ 3 and 44 Ϯ 3 nmol ATP/mg protein, respectively, n ϭ 3, P ϭ not significant (NS)] or the percentage of ATP breakdown during chemical hypoxia (Table 1) . Cardiomyocyte viability measured by LDH release was Ͼ98% in both ␤-galactosidase-and cN-IA-transduced cells. Only in cN-IA-transduced cells treated with DOG and cyanide was LDH marginally elevated (Table 1) .
Transduction with cN-IA profoundly altered the pattern of ATP metabolites produced in either the presence or absence of inhibitors of adenosine metabolism (Fig. 2, A and B) . Figure 2 summarizes the pattern of nucleotide metabolism in representative experiments.
Overexpression of cN-IA increased adenosine production (Fig. 2, A and B) , even in the absence of inhibitors of adenosine metabolism ( Fig. 2A) . cN-IA overexpression increased adenosine production at the expense of IMP, inosine, and hypoxanthine, as most clearly seen in the presence of inhibitors of adenosine metabolism (Fig. 2B) . This demonstrates competition between cN-IA and AMP deaminase for the available cytosolic AMP. Only with DOG and cyanide, when ATP is most depleted, did AMP accumulate in ␤-galactosidasetransduced cells (Fig. 2, A and B) . This is probably due to the inhibition of AMP deaminase known to occur under such conditions (20) . With DOG and cyanide, cN-IA overexpression reduced the final AMP concentration. Averaged data from several experiments (Fig.  3, A and B) demonstrate that even under baseline conditions, cN-IA overexpression significantly increased the concentration of adenosine in the presence or absence of inhibitors of adenosine metabolism (Fig.  3, A and B) . Moreover, cN-IA overexpression dramatically potentiated the stimulatory effects of simulated hypoxia on adenosine concentration (Fig. 3, A and B) . The patterns of changes after simulated hypoxia were similar in the absence of inhibitors of adenosine metabolism, although the absolute levels of adenosine achieved were approximately halved (Fig. 3, A and B) . As expected, there was correspondingly more inosine and hypoxanthine in the absence of inhibitors of adenosine metabolism than in their presence (Fig. 2, A  and B) . In agreement with our previous work in rat neonatal cardiomyocytes (21) , inclusion of the selective e-N inhibitor ␣,␤-methylene-adenosine diphosphate (AOPCP; 50 M) did not affect adenosine formation under any condition of simulated hypoxia (data not shown and see below).
We conducted a separate set of experiments in which medium and cells were analyzed separately. Values for adenosine concentration in the medium (Fig. 4) were similar to those measured in cells plus medium (Fig.  3B) , which shows that most of the adenosine was present in the medium, as we (21) previously reported. Medium adenosine concentrations were not affected by inclusion of AOPCP either under baseline or after treatment with DOG and cyanide. However, the nucleoside transport inhibitor dipyridamole dramatically reduced medium adenosine concentrations. Adenosine concentrations in the cells were below the limits of accurate measurement except in the case of DOG plus cyanide plus dipyridamole, when they were fourfold the extracellular concentration. Conversely, ATP, ADP, or AMP concentrations were not measurable by HPLC in the medium under any condition (data not shown). These data confirm our previous study (21) , which showed that the overwhelming majority of adenosine is formed intracellularly in neonatal rat cardiomyocytes, independently of e-N, and then transported out. Not surprisingly, overexpression of cN-IA increased intracellular adenosine formation.
Effect of cN-IA overexpression on nucleotide metabolism and beating frequency after stimulation with isoproterenol.
The increase in total (cells plus medium) adenosine concentration resulting from overexpression of cN-IA persisted in the presence of 20 M isoproterenol whether or not inhibitors of adenosine metabolism were also present (Fig. 5A) . In a separate series of experiments, we measured adenosine concentration in the medium alone. Medium adenosine concentrations were also significantly greater in cN-IA-than ␤-galactosidase-transduced cells, and this difference again persisted in the presence of isoproterenol (Fig. 5B) . The difference between cN-IA-and ␤-galactosidase-transduced cells was preserved in the presence of AOPCP but lost in the presence of dipyridamole (Fig. 5B) . These data confirm that cN-IA overexpression led to an increase in adenosine formation and release, which was present both before and after isoproterenol treatment.
Isoproterenol significantly and reversibly increased the beating frequency of cardiomyocytes transduced with ␤-galactosidase (Fig. 6A) . The effect of isoproterenol was not reversed by including inhibitors of adenosine metabolism but was by adding 50 M adenosine, which had no effect on beating frequency in the absence of isoproterenol (Fig. 4A and data not shown) . In contrast, isoproterenol did not increase beating frequency in cardiomyocytes overexpressing cN-IA (Fig.  6A) . To confirm that these effects were mediated through adenosine receptors, the experiments were repeated in the presence of a nonselective adenosine receptor antagonist, 8-(p-sulfophenyl)theophylline (8-SPT). 8-SPT had no effect on the ability of isoproterenol to stimulate beating frequency but partially antagonized the inhibition of this by added adenosine (Fig.  6B ). More importantly, however, 8-SPT completely abolished the inhibitory effect of cN-IA overexpression on isoproterenol-induced beating frequency (Fig. 6B) .
DISCUSSION
cNs were first characterized and named based on kinetic and physical properties during purification from avian, rodent, and human hearts. So-called cN-II was the first to be cloned from the chicken and human (26) . It is a tetramer of 60-kDa subunits and prefers IMP (K m ϳ0.2 mM) over AMP (K m ϳ5 mM). It is activated in vitro by ATP or ADP and inhibited by inorganic phosphate, which implies a biphasic response during ATP breakdown that has been confirmed in whole cell experiments (38) . So-called cN-I was later cloned from the pigeon, human, and mouse (14, 29, 30) . Although cN-I and cN-II may share similar catalytic residues (1), they are genetically unrelated. The purified enzyme is a tetramer of 40-kDa subunits that has a preference for AMP (K m ϳ5 mM) compared with IMP (K m ϳ20 mM). It is insensitive to inorganic phosphate and requires a nucleoside diphosphate (e.g., ADP) for maximum activity (nucleoside triphosphates cannot act as substitutes). These kinetic characteristics suggest that the enzyme is active during ATP catabolism when AMP, ADP, and inorganic phosphate concentrations rise. Inhibitors selective for cN-I over cN-II are dideoxynucleosides (particularly ddC and ddU), and these have been shown to decrease adenosine production from rat myocytes (10) . This was the first direct evidence that cN-I could contribute to adenosine formation in cells. The role of cN-I was confirmed by plasmid-based overexpression studies, which demonstrated the ability of cloned cN-IA to produce adenosine in established cell lines in the presence of inhibitors of adenosine metabolism (28, 30) .
Sequencing studies recently distinguished two isoforms of cN-I encoded by genes on human chromosomes 1 and 2, respectively. The form purified and kinetically characterized from the pigeon heart and later used for protein sequencing and cloning was designated cN-IA (29) . The kinetic properties of cN-IB have yet to be fully elucidated, although its basic characteristics in terms of K m , activation by AMP, insensitivity to inorganic phosphate, and inhibition by dideoxynucleosides appear similar to cN-IA. Moreover, both isoforms can generate adenosine during ATP catabolism when overexpressed in COS-7 cells (29) . Because cN-IA is abundantly expressed in the heart, whereas cN-IB is poorly expressed in the heart and predominates in the testis, we chose to focus on cN-IA in these experiments. Furthermore, because the kinetic properties of purified and cloned cN-IA are highly conserved across species from the pigeon to human (35, 36) , we chose to overexpress the pigeon enzyme, for which we had suitable full-length clones.
The high K m for AMP of cN-I (ϳ5 mM) has cast doubts on its physiological function in myocardial adenosine formation because the predicted concentrations of free cytosolic AMP in cardiomyocytes are in the micromolar range. On the other hand, AMP deaminase also has a relative high K m for AMP, ϳ0.6 mM, which increases to ϳ2.4 mM in the absence of ATP (20) . Some cellular fractionation and histological evidence has implied that both cN-I and AMP deaminase may be associated with contractile fibers and therefore in a microenvironment exposed to higher AMP concentrations (27, 30) . A further concern has been that any adenosine produced in the cytoplasm would have to escape metabolism by adenosine kinase and adenosine deaminase and be transported out through the equilibrative nucleoside transporter before it could activate extracellular adenosine receptors. There remain doubts, therefore, as to whether cN-I could sufficiently elevate adenosine concentrations in primary cardiomyocytes in the face of adenosine metabolism to act at adenosine receptors. To investigate this question, we first had to develop an adenovirus, which we showed capable of achieving high-level expression of cN-IA in primary cardiomyocytes. Our second goal was to measure adenosine formation and release during simulated hypoxia in the presence of inhibitors of adenosine metabolism. Although these experiments were not designed to measure the initial rates of adenosine formation, we can calculate that 20 nmol of adenosine were produced over 10 min in cN-IA-transduced cells, which compares with a V max of nearly 900 nmol ⅐ min Ϫ1 ⅐ mg protein Ϫ1 . Clearly the enzyme operates under far from saturating conditions, consistent with the low free cytosolic AMP concentrations. Furthermore, by suppressing IMP, ino- sine, and hypoxanthine concentrations, we showed that cN-IA effectively competed for substrate with AMP deaminase. Most importantly, we showed, for the first time, that the enzyme was sufficiently active to elevate adenosine concentrations even in the absence of inhibitors of adenosine metabolism.
All previous studies demonstrating adenosine formation from recombinant cN-I overexpression have used extreme conditions of ATP depletion. We showed here, however, that overexpression of cN-I provoked adenosine formation and elevated extracellular adenosine concentrations even under baseline conditions, when ATP levels were only 8% less than in ␤-galactosidasetransduced cells.
Finally, we sought to investigate whether cN-IA over expression could influence a response to adenosine mediated by extracellular adenosine receptors. Because neonatal myocytes are anchored to the substratum, cell shortening could not be quantified. Hence, the most convenient parameter to measure was beating frequency. As previously shown (12) , isoproterenol exerts a positive chronotropic effect on neonatal cardiomyocytes. This does not appear to be under tonic control by adenosine because 8-SPT, a nonselective competitive inhibitor of adenosine receptors, had no stimulatory effect on the beating rate. However, added adenosine reversed the effect of isoproterenol, and this appeared to be receptor mediated. The partial effect of 8-SPT can be explained by the relatively high concentration of added adenosine used. Overexpression of cN-I produced a similar effect to added adenosine, which was in this case fully reversed by 8-SPT. The increase in adenosine formation and release by cN-IA overexpression persisted in the presence of isoproterenol and, from inhibitor experiments, was again independent of e-N but depended on nucleoside transport. The concentration of adenosine found in ␤-galactosidase-and cN-IA-transduced cardiomyocytes in the presence of isoproterenol ranged from 0.1 to 0.6 M, which is in the range known to be effective at adenosine receptors (34) . These results show, again for the first time, that cN-IA can generate sufficient concentrations of adenosine to exert physiological effects on cell surface receptors even in the face of adenosine metabolism.
Limitations. While our overexpression studies demonstrate the potential of cN-IA to produce adenosine in cardiomyocytes, they clearly do not directly address the role of cN-IA in regulating myocardial adenosine concentrations and physiological actions in the heart. This will ultimately require transgenic and knockout experiments in mice for which our present experiments provide necessary justification. The extracellular compartment in the intact myocardium is much smaller in proportion to that in isolated cardiomyocyte cultures, and this would tend to potentiate the extracellular concentration of any adenosine formed in the cytoplasm and released from the nucleoside transporter. In this sense, our experiments in isolated cardiomyocytes represent rather stringent conditions to test the role of cN-IA, which we compensated for by overexpressing the enzyme. A further limitation of our study is that we focused on cardiomyocytes. Because endothelial cells also contribute to adenosine formation in the heart (6), future studies addressing the role of cN-I in those cells would also be valuable.
In conclusion, our studies demonstrate, for the first time, the activity of cloned cN-IA in primary rat cardiomyocytes. They demonstrate that cN-IA is sufficiently active to significantly increase adenosine concentration in the absence of inhibitors of adenosine metabolism and mediate physiological responses to adenosine at extracellular receptors.
